- Home
- PNF vs FORA Comparison
PNF vs FORA Comparison
Compare PNF & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNF
- FORA
- Stock Information
- Founded
- PNF 2001
- FORA 2014
- Country
- PNF United States
- FORA United States
- Employees
- PNF N/A
- FORA N/A
- Industry
- PNF Finance Companies
- FORA Computer Software: Prepackaged Software
- Sector
- PNF Finance
- FORA Technology
- Exchange
- PNF Nasdaq
- FORA Nasdaq
- Market Cap
- PNF 59.6M
- FORA 62.7M
- IPO Year
- PNF N/A
- FORA N/A
- Fundamental
- Price
- PNF $7.51
- FORA $1.91
- Analyst Decision
- PNF
- FORA Strong Buy
- Analyst Count
- PNF 0
- FORA 1
- Target Price
- PNF N/A
- FORA $5.00
- AVG Volume (30 Days)
- PNF 29.1K
- FORA 7.9K
- Earning Date
- PNF 01-01-0001
- FORA 03-27-2025
- Dividend Yield
- PNF 5.17%
- FORA N/A
- EPS Growth
- PNF N/A
- FORA N/A
- EPS
- PNF N/A
- FORA N/A
- Revenue
- PNF N/A
- FORA $19,709,723.00
- Revenue This Year
- PNF N/A
- FORA N/A
- Revenue Next Year
- PNF N/A
- FORA $13.59
- P/E Ratio
- PNF N/A
- FORA N/A
- Revenue Growth
- PNF N/A
- FORA N/A
- 52 Week Low
- PNF $6.37
- FORA $1.90
- 52 Week High
- PNF $9.06
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- PNF 42.37
- FORA 38.63
- Support Level
- PNF $7.44
- FORA $1.90
- Resistance Level
- PNF $7.76
- FORA $2.13
- Average True Range (ATR)
- PNF 0.09
- FORA 0.09
- MACD
- PNF -0.01
- FORA -0.01
- Stochastic Oscillator
- PNF 30.53
- FORA 3.45
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.